Author:
Emuss Victoria,Boshoff Chris
Reference88 articles.
1. Proceedings of the IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Epstein-Barr Virus and Kaposi’s Sarcoma Herpesvirus/Human Herpesvirus 8. Lyon, France, 17–24 June 1997. IARC Monogr Eval Carcinog Risks Hum, 1997, 70: 1–492.
2. Alitalo K, Carmeliet P. Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell 2002, 1: 219–27.
3. Antman K, Chang Y. Kaposi’s sarcoma. N Engl J Med 2000, 342: 1027–38.
4. Aoki Y, Tosato G. HIV-1 Tat enhances Kaposi sarcoma-associated herpesvirus (KSHV) infectivity. Blood 2004, 104: 810–4.
5. Ariad S, et al. Early peripheral lymph node involvement of human herpesvirus 8-associated, body cavity-based lymphoma in a human immunodeficiency virus-negative patient. Arch Pathol Lab Med 2000, 124: 753–5.